DIM
Best-in-class: DIM + Crucera-SGS
A compound formed in the stomach from indole-3-carbinol in cruciferous vegetables. Widely used to 'balance estrogen', which oversimplifies what it actually does.
DIM quick facts
| Suggested dose | 100–200 mg daily with food. |
| How often | daily |
| Who it's for | Estrogen metabolism support; sometimes used alongside TRT. |
Human trials confirm the ratio shift, which is more than most estrogen-metabolism supplements can show. It is gentler and more defensible than crushing estradiol with an aromatase inhibitor. It induces CYP1A2, which alters clearance of several medications. Harmless bright orange urine is common and alarms people. Requires adequate methylation downstream to finish the job.
How DIM actually works
Diindolylmethane shifts estrogen metabolism at the phase-I hydroxylation step, favoring the 2-hydroxy pathway over the 16-alpha and 4-hydroxy routes. That matters because 2-hydroxyestrone is relatively inert while 4-hydroxy metabolites can form DNA-damaging quinones. So DIM changes which metabolites you make rather than how much estrogen you have — a genuinely different intervention from aromatase inhibition.
Where to get DIM
Buy DIM + Crucera-SGS at Thorne →The evidence for DIM
Graded by what exists behind each claim.
✅ Clinically validated
- Human trials are limited and mostly focused on cervical dysplasia and prostate outcomes, with mixed results. There is no good trial evidence for the general hormone-balancing claim.
📊 Correlative data
- The observational foundation is dietary rather than supplemental: populations with higher cruciferous vegetable intake show lower rates of several hormone-sensitive cancers, and DIM is a compound formed from glucosinolates during digestion. Whether isolated DIM reproduces that is not established.
🧪 Theoretical / extrapolated benefits
- Shifts estrogen metabolism toward the 2-hydroxy pathway and away from 16-alpha-hydroxy, which is the basis of the claim. Whether that shift produces clinical benefit in healthy people is unestablished.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What DIM actually does
DIM is a stomach-acid product, and the plant never makes it. Brassica vegetables store glucobrassicin, a glucosinolate. Chewing or chopping releases myrosinase, which hydrolyzes it to an unstable isothiocyanate that rearranges to indole-3-carbinol. In gastric acid two molecules of indole-3-carbinol condense to 3,3'-diindolylmethane, along with a series of larger oligomers including the cyclic trimer Williams 2021. A DIM capsule skips that chemistry and delivers the condensation product directly, which is a real advantage in reproducibility and a real loss in fidelity to what a vegetable does.
The receptor it acts on is the aryl hydrocarbon receptor, which is a xenobiotic sensor rather than a hormone receptor. DIM is a weak agonist; the liganded receptor translocates to the nucleus, dimerizes with ARNT and transcribes CYP1A1, CYP1A2 and CYP1B1 through xenobiotic response elements. Those are the enzymes that hydroxylate estradiol and estrone, and they are also the enzymes that activate several procarcinogens, which is why the same induction is cited as a benefit and as a risk depending on who is writing Reyes-Hernández 2023.
The estrogen claim is a claim about which carbon gets hydroxylated. CYP1A1 and CYP1A2 favor 2-hydroxylation, giving 2-hydroxyestrone; CYP3A4 and CYP1B1 favor 16-alpha- and 4-hydroxylation. The 2-hydroxy metabolites are weakly estrogenic and quickly methylated by catechol-O-methyltransferase for excretion; 16-alpha-hydroxyestrone retains receptor activity and binds covalently to protein. Shifting the ratio toward the 2-position is the entire mechanistic story sold on the label.
DIM also does things that have nothing to do with estrogen. It antagonizes the androgen receptor at micromolar concentrations, inhibits nuclear factor kappa B signaling, activates AMP-activated protein kinase, and induces phase II conjugation through NRF2 — a spread of activities wide enough that attributing any clinical observation to the estrogen pathway specifically is an assumption rather than a finding Reyes-Hernández 2023.
And the ratio is a ratio of urinary metabolites, which is the quiet problem. The 2-hydroxyestrone to 16-alpha-hydroxyestrone ratio is measured in urine, varies with collection timing, renal function and menstrual phase, and describes disposal rather than exposure. Nothing about a shifted ratio tells you that circulating estradiol changed.
Cell, rodent, human — and where it stops
This is the purest example in the cohort: the marker is the only endpoint anybody has measured, and it is not a disease.
In cells and rodents, DIM does a great deal. Growth arrest, apoptosis induction, aryl hydrocarbon receptor activation and androgen receptor antagonism all reproduce in culture; rodent chemoprevention models show reduced tumor incidence with dietary indoles. The doses are large and the models are carcinogen-initiated, which is a specific and artificial setting Williams 2021.
In humans the pharmacology was, until recently, assumed rather than measured. Controlled dosing in people showed that DIM undergoes significant metabolism after oral administration, with mono- and dihydroxylated metabolites and their conjugates dominating the circulating profile Vermillion Maier 2021. That matters because in vitro work uses the parent compound and people do not circulate much of it.
The one human experiment that tested a downstream consequence used a carcinogen probe, not a cancer. Supplementing volunteers with DIM or with Brussels sprouts altered benzo[a]pyrene toxicokinetics after a micro-dose Vermillion Maier 2023. That is a genuine demonstration that the enzyme induction happens in people. It is also a demonstration about a probe compound, and it does not say whether the direction is protective.
In the hormonal setting the newest work goes to the obvious question and gets a mixed answer. In postmenopausal women using a transdermal estradiol patch, DIM changed estrogen metabolism measures Newman 2025. Metabolism measures. Not symptom scores, not breast density, not endometrial thickness, not recurrence.
The obstacle to transfer is that the ratio was adopted as a risk marker on epidemiology that has not held up uniformly. Case-control studies associating a low 2:16 ratio with breast cancer risk were followed by prospective cohorts that found weak or absent associations. A supplement that reliably moves a marker whose own prognostic value is contested is two inferential steps away from a health claim, and both steps are unfunded.
DIM — which form, and does it matter
DIM against indole-3-carbinol is a real choice and DIM is the more defensible one. Indole-3-carbinol is unstable in acid by design and produces an uncontrolled mixture of oligomers whose proportions depend on gastric pH, transit time and dose Williams 2021. DIM is a defined molecule. Anyone reasoning from indole-3-carbinol trials to a DIM product is crossing a chemistry boundary that the stomach was doing invisibly.
Crystalline DIM is nearly insoluble, so the formulation is the dose. Absorption of unformulated DIM is poor and erratic. Microencapsulated or absorption-enhanced preparations — the starch-particle formulations used in most clinical studies — raise exposure severalfold, which means 100 mg of one product and 100 mg of another are not comparable and a label rarely says which it is.
The pharmacokinetics are now measured rather than assumed. After oral dosing, plasma DIM peaks in roughly 2 hours and is cleared over several hours, and the dominant circulating species are hydroxylated metabolites and their glucuronide and sulfate conjugates rather than the parent Vermillion Maier 2021. The hydroxylation is itself cytochrome P450 mediated, so DIM induces the enzymes that clear it — a self-limiting exposure with a first-pass component and predominantly biliary and renal clearance of conjugates.
The Crucera pairing in this catalog is a different molecule. A DIM product formulated with a glucoraphanin-bearing broccoli seed extract is delivering two separate pathways: DIM to the aryl hydrocarbon receptor and sulforaphane to NRF2. Neither has been tested against the other, and no trial has established that the combination outperforms either alone.
What no form fixes is the vegetable comparison. A 200 g serving of Brussels sprouts delivers glucobrassicin, myrosinase and several dozen other glucosinolates, and the condensation happens in the stomach with everything else present. A capsule delivers one of the products. The trial that ran both arms did so for a toxicokinetic endpoint, and it is the only place the two have been compared at all Vermillion Maier 2023.
What would have to be true, and how you would know it was not
1. The urinary ratio will move, and that is the least interesting prediction on this page. Predict the 2-hydroxyestrone to 16-alpha-hydroxyestrone ratio rises within 4 to 8 weeks on 100 to 200 mg of an absorption-enhanced product. It is the marker the supplement owns and it will do what the mechanism says.
2. Predict circulating hormones do not change. Estradiol, sensitive (LC/MS-MS), total testosterone, SHBG and total estrogens should be unchanged at 12 weeks, because shifting disposal between two hydroxylation routes is not the same as changing production. If estradiol falls materially on DIM alone, something other than the labeled mechanism is happening and it is worth investigating rather than celebrating.
3. The prediction that cuts against the product. Predict that no randomized trial exists in which a DIM-induced shift in the estrone ratio is followed by a change in any clinical outcome — not breast density, not cyclical mastalgia, not recurrence, not prostate-specific antigen. A trial reporting one would falsify this page's central claim Newman 2025.
4. Predict a caffeine interaction you can feel. CYP1A2 induction is the best-supported human consequence of this compound, and CYP1A2 clears caffeine. Predict that habitual coffee drinkers notice caffeine wearing off faster within a few weeks of starting DIM. That is a crude but genuinely falsifiable read-out of whether the enzyme induction reached the liver.
5. Predict thyroid tests stay put, and check them if the reason for taking it is hormonal. Brassica compounds have a goitrogen reputation that belongs mostly to progoitrin rather than to DIM. Predict no change in TSH or free T4 at 12 weeks; a drift in either is a reason to stop and to look at iodine intake rather than to raise the dose.
What nobody has tested yet
The outcome trial does not exist in any indication. DIM has been studied for cervical intraepithelial neoplasia, prostate cancer and mastalgia in small trials, and no adequately powered randomized trial has reported a clinical endpoint. The compound has been sold for two decades on a urinary ratio Reyes-Hernández 2023.
Nobody knows whether the metabolites are the actives. Human dosing produces mono- and dihydroxylated DIM in quantity Vermillion Maier 2021, and essentially all of the mechanistic work was done with the parent compound. Whether the circulating metabolites activate the aryl hydrocarbon receptor, are inert, or oppose it has not been established.
The direction of the carcinogen effect is unresolved. Inducing CYP1A1 and CYP1B1 accelerates both the detoxification of some compounds and the bioactivation of others, and the human toxicokinetic study establishes that the induction is real without establishing which way it points for any real-world exposure Vermillion Maier 2023.
And the ratio's own prognostic value has never been settled prospectively. Before anybody asks whether DIM improves outcomes by raising the 2:16 ratio, somebody would have to establish that a raised ratio predicts anything in a cohort followed forward. That study has been called for repeatedly and not delivered.
DIM — its own safety story, not its category's
The commonest effect is cosmetic and alarming. DIM and its metabolites color urine orange or amber, sometimes brightly, within a day or two of starting. It is harmless, it is not hematuria, and it is the single most frequent reason people stop.
The risk that is not cosmetic is enzyme induction. A compound whose best-documented human action is transcribing CYP1A1 and CYP1A2 will lower the concentration of drugs those enzymes clear. Theophylline, tizanidine, clozapine, olanzapine, duloxetine, melatonin and caffeine are all CYP1A2 substrates, and for several of them the therapeutic window is narrow enough that a 30 percent reduction matters Reyes-Hernández 2023.
Hormone-modifying therapy is where this needs a clinician rather than a page. DIM changes estrogen metabolism in women on transdermal estradiol Newman 2025, so anyone on hormone replacement, on tamoxifen or an aromatase inhibitor, or on hormonal contraception is combining two interventions aimed at the same pathway. This page will not estimate the direction of that combination.
Dose-related effects at the top of the range. Headache and nausea are reported and are dose-dependent. A small number of case reports describe hyponatremia and, separately, reversible central serous retinopathy at high supplemental doses, which is the sort of signal that a compound sold without outcome trials accumulates slowly and quietly.
Who should not take it. Pregnancy and lactation, for lack of data on a compound that induces fetal-relevant enzymes. Anyone with a hormone-sensitive cancer, because the mechanism is aimed directly at that pathway and the evidence is a urinary ratio. Nothing here is medical advice or diagnosis, and these statements have not been evaluated by the Food and Drug Administration.
Sources read for this page
- Vermillion Maier ML. 3,3'-Diindolylmethane Exhibits Significant Metabolism after Oral Dosing in Humans. Drug Metab Dispos 2021 · PMID 34035125
- Vermillion Maier ML. Benzo[a]pyrene toxicokinetics in humans following dietary supplementation with 3,3'-Diindolylmethane (DIM) or Brussels sprouts. Toxicol Appl Pharmacol 2023 · PMID 36642108
- Newman MS. The impact of 3,3'-diindolylmethane on estradiol and estrogen metabolism in postmenopausal women using a transdermal estradiol patch. Menopause 2025 · PMID 40298801
- Williams DE. Indoles Derived From Glucobrassicin: Cancer Chemoprevention by Indole-3-Carbinol and 3,3'-Diindolylmethane. Front Nutr 2021 · PMID 34660663
- Reyes-Hernández OD. 3,3'-Diindolylmethane and indole-3-carbinol: potential therapeutic molecules for cancer chemoprevention and treatment via regulating cellular signaling pathways. Cancer Cell Int 2023 · PMID 37633886
How you would know if it worked
This has the clearest single number of anything in its category, and the reason to draw it is that the popular direction of travel is the wrong one. Sensitive estradiol by mass spectrometry is the test, not the standard immunoassay, which is unreliable at male concentrations. Draw it before, and six to eight weeks after. What you want back is not a lower number but a normal one: estradiol is the dominant regulator of bone density in men, and driving it down buys joint pain, flat libido and worse lipids in exchange for a symptom estradiol was probably not causing. Total estrogens sits beside it for the case where symptoms and estradiol disagree. And if nothing moves at all, that is the likeliest outcome — the general hormone-balancing claim has no trial behind it, only a shift in which metabolites estrogen becomes.
- Estradiol, Sensitive (LC/MS-MS) Retest: 6–8 weeks after any TRT or AI change.
- Estrogens, Total Retest: With estradiol.
Draw before you start, not after. A result with nothing to compare it to answers nothing.
DIM — safety & side effects
- Harmless orange urine is the most common effect and alarms people every time. Headache and nausea also occur, usually at higher doses.
- Shifts estrogen metabolism, so it can change how hormonal contraception and HRT behave. It also induces CYP1A2, which speeds clearance of caffeine and some medications.
The same on every page it applies to. Read it here; it is not repeated research.
- Avoid if you have or have had a hormone-sensitive cancer (breast, ovarian, uterine, prostate) without oncology input. The mechanism that makes it useful is the mechanism that makes it a question in that setting.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
- When to take it, and what to take it with
- Which form actually absorbs
- Who it's worth it for
- Best-in-class brand pick
- Coach Cam's stacks and notes
- Fasted or with food, and when in the day
- Morning or night, and why that window
- Around training, or deliberately away from it
- What it must not share a window with
Everything above is free and stays free. Skool is where it becomes a plan — DIM in an order, with the rest of what you're running.
Unlock in Skool — $10/mo →Bloodwork to run alongside DIM
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| Estradiol, Sensitive (LC/MS-MS) | DIM shifts estrogen metabolism — this is where that shows |
| Total Testosterone | The androgen half of the picture |
| SHBG (Sex Hormone-Binding Globulin) | Determines how much of either is actually active |
| Comprehensive Metabolic Panel (CMP) | Liver, since this is where estrogen metabolism happens |
The Adult Hormonal Acne panel covers these in one order — 8 markers, $186.30 with the discount applied.
Check results you already have → · All 103 markers A–Z
DIM — frequently asked questions
What is DIM?
A compound formed in the stomach from indole-3-carbinol in cruciferous vegetables. Widely used to 'balance estrogen', which oversimplifies what it actually does.
What is the suggested dose of DIM?
100–200 mg daily with food. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
Where can I find DIM dosing and the full breakdown?
The suggested dose and the full evidence — clinical, correlative and theoretical — are on this page. What's inside Skool is when to take it, which form actually absorbs, the brand worth buying and Coach Cam's stacks.
Where can I buy DIM?
Coach Cam sources DIM from Thorne, with 10% off auto-applied at checkout — use the buy link on this page.
DIM inside a finished plan
One arm of 3 Protocol Blueprints, free to read in full.
What DIM is used for
DIM appears under 3 goals in the goal router.
Related Hormonal & Wellness supplements
Where this goes next
DIM is the aromatase arm of this plan. The page above is the free breakdown of one compound; the plan it belongs to — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.